Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week

Page 2 of 2

As for Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), its outlook for success depend on how effectively the company defends itself. There have been past examples of this type of attack from a short-seller go down in flames as the allegations are proven to be overblown. On the other hand, if doubts linger in the minds of investors, there can be a longer-term impact on the stock.

Good news from the elagolix late-stage tests could help Neurocrine Biosciences, Inc. (NASDAQ:NBIX) bounce back. However, those results are a year in the future. For now, I look for the stock to experience a bit of winter after its fall. Maybe positive results in 2014 and a strong partnership with AbbVie Inc (NYSE:ABBV) can help Neurocrine spring forward down the road.

The article 3 Horrendous Health-Care Stocks This Week originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights and The Motley Fool have no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2